{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:18:50Z","timestamp":1783030730073,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"University Grants Committee Research Grants Council","doi-asserted-by":"publisher","award":["17111922"],"award-info":[{"award-number":["17111922"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopsych.2026.02.015","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:51:54Z","timestamp":1772643114000},"page":"170-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A 20-Year Population-Based Follow-Up Study on the Association Between Clozapine and Hospitalization in People With Treatment-Resistant Schizophrenia"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1499-9735","authenticated-orcid":false,"given":"Huiquan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Yee-Man","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Sai Yu","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin Ho Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2712-5826","authenticated-orcid":false,"given":"Sherry Kit Wa","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2026.02.015_bib1","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/schbul\/sbae043","article-title":"Update of the World Health Organization\u2019s Mental Health Gap Action Programme guideline for psychoses (including schizophrenia)","volume":"50","author":"Lorenz","year":"2024","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2026.02.015_bib2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/schbul\/sbaa145","article-title":"Predictors of treatment-resistant and clozapine-resistant schizophrenia: A 12-year follow-up study of first-episode schizophrenia-spectrum disorders","volume":"47","author":"Chan","year":"2021","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2026.02.015_bib3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: Treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.02.015_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/YIC.0b013e32836508e6","article-title":"The social and economic burden of treatment-resistant schizophrenia: A systematic literature review","volume":"29","author":"Kennedy","year":"2014","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2026.02.015_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s40263-022-00932-2","article-title":"A guideline and checklist for initiating and managing clozapine treatment in patients with treatment-resistant schizophrenia","volume":"36","author":"Correll","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopsych.2026.02.015_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-244X-14-102","article-title":"Clozapine: A review of clinical practice guidelines and prescribing trends","volume":"14","author":"Warnez","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.biopsych.2026.02.015_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamapsychiatry.2015.2955","article-title":"Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: A network meta-analysis","volume":"73","author":"Samara","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2026.02.015_bib8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S2215-0366(25)00001-X","article-title":"Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: A systematic review and individual patient data meta-analysis","volume":"12","author":"Schneider-Thoma","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.biopsych.2026.02.015_bib9","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/jamapsychiatry.2019.1702","article-title":"Association hospitalization all-cause discontinuation among patients schizophrenia clozapine vs other oral second-generation antipsychotics: A systematic review meta-analysis cohort studies","volume":"76","author":"Masuda","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2026.02.015_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/acps.12700","article-title":"The impact of clozapine on hospital use: A systematic review and meta-analysis","volume":"135","author":"Land","year":"2017","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2026.02.015_bib11","article-title":"Impact of community mental health services on the adult psychiatric admission through the emergency unit: A 20-year population-based study","volume":"39","author":"Ma","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.biopsych.2026.02.015_bib12","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1017\/S0033291714002220","article-title":"10-year outcome study of an early intervention program for psychosis compared with standard care service","volume":"45","author":"Chan","year":"2015","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2026.02.015_bib13","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jamapsychiatry.2017.1322","article-title":"Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29 823 patients with schizophrenia","volume":"74","author":"Tiihonen","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2026.02.015_bib14","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.23m15071","article-title":"Beneficial effects concomitant long-acting injectable antipsychotics time rehospitalization patients treatment-resistant schizophrenia receiving clozapine: A retrospective cohort study","volume":"85","author":"Tien","year":"2024","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2026.02.015_bib15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/pds.5227","article-title":"Control yourself: ISPE-endorsed guidance in the application of self-controlled study designs in pharmacoepidemiology","volume":"30","author":"Cadarette","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.biopsych.2026.02.015_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104315","article-title":"The reliability of medication and death recording in electronic health records among people with schizophrenia in Hong Kong","volume":"103","author":"Zhou","year":"2025","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.biopsych.2026.02.015_bib33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.biopsych.2026.02.015_bib17","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S2215-0366(22)00158-4","article-title":"Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: A systematic review and network meta-analysis","volume":"9","author":"Ostuzzi","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.biopsych.2026.02.015_bib18","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/NMD.0000000000001607","article-title":"Impact of severe acute respiratory syndrome, Coronavirus disease 2019, and social unrest on adult psychiatric admissions in Hong Kong: A comparative population-based study","volume":"211","author":"Ma","year":"2023","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.biopsych.2026.02.015_bib19","doi-asserted-by":"crossref","DOI":"10.1192\/bjp.2025.10312","article-title":"Population-based study of long-term mortality risk associated with clozapine use among patients with schizophrenia [published online Jul 4]","author":"Zhou","year":"2025","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.02.015_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.schres.2023.11.008","article-title":"A systematic review of clozapine for aggression and violence in patients with schizophrenia or schizoaffective disorder","volume":"268","author":"Faden","year":"2024","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2026.02.015_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: A systematic review and network meta-analysis","volume":"7","author":"Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.biopsych.2026.02.015_bib22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s40263-017-0461-9","article-title":"Cardiovascular disease in clozapine-treated patients: Evidence, mechanisms and management","volume":"31","author":"Ronaldson","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopsych.2026.02.015_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2017.03.045","article-title":"Elevated clozapine levels associated with infection: A systematic review","volume":"192","author":"Clark","year":"2018","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2026.02.015_bib24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S2215-0366(21)00039-0","article-title":"Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: A systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies","volume":"8","author":"Kishimoto","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.biopsych.2026.02.015_bib25","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/acps.13621","article-title":"Clozapine augmentation with long-acting antipsychotic injections: A case series and systematic review","volume":"148","author":"Oloyede","year":"2023","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2026.02.015_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jamapsychiatry.2018.4320","article-title":"Association of antipsychotic polypharmacy vs monotherapy with psychiatric rehospitalization among adults with schizophrenia","volume":"76","author":"Tiihonen","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2026.02.015_bib27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/schbul\/sbx090","article-title":"Effectiveness of long-acting injectable vs oral antipsychotics in patients with schizophrenia: A meta-analysis of prospective and retrospective cohort studies","volume":"44","author":"Kishimoto","year":"2018","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2026.02.015_bib28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/schbul\/sbu128","article-title":"Comparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: Results from a nationwide, retrospective inception cohort study","volume":"41","author":"Nielsen","year":"2015","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2026.02.015_bib29","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/ijnp\/pyad053","article-title":"Schizophrenia patients discharged on clozapine plus long-acting injectable antipsychotics from a public psychiatric hospital in Taiwan, 2006-2021","volume":"26","author":"Lin","year":"2023","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2026.02.015_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2025.1594334","article-title":"Sex differences in schizophrenia: Symptomatology, treatment efficacy and adverse effects","volume":"16","author":"Moniem","year":"2025","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopsych.2026.02.015_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/20451253241263715","article-title":"Long-acting antipsychotic treatments: Focus on women with schizophrenia","volume":"14","author":"Brissos","year":"2024","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.biopsych.2026.02.015_bib32","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1007\/s00213-022-06241-2","article-title":"A systematic review on the use of clozapine in treatment of tardive dyskinesia and tardive dystonia in patients with psychiatric disorders","volume":"239","author":"Wong","year":"2022","journal-title":"Psychopharmacology"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322326000922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322326000922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:35:39Z","timestamp":1783028139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322326000922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0006322326000922"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2026.02.015","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 20-Year Population-Based Follow-Up Study on the Association Between Clozapine and Hospitalization in People With Treatment-Resistant Schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2026.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}